Figure 2 shows the effects of the administration of oleuropein, hydroxytyrosol and a mixture of both compounds for five days on tumor growth in our experimental glioma model on RAS-regulating aminopeptidases. The gene discussed is CPQ; the disease is central nervous system cancer.